Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma

Journal of Neurosurgery

Volumn 84, Issue 5, 1996, Pages 847-851

  Harada, Takehiko ^a   Irving, Richard M ^b   Xuereb, John H ^b   Barton, David E ^b   Hardy, David G ^b   Moffat, David A ^b   Maher, Eamonn R ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

chromosome 22; genetic mutation; meningioma; molecular genetics; NF2 gene

Indexed keywords

DNA;

ARTICLE; CHROMOSOME 22; CHROMOSOME LOSS; CLINICAL ARTICLE; DNA SEQUENCE; HUMAN; HUMAN TISSUE; MENINGIOMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0029875198     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1996.84.5.0847     Document Type: Article

References (29)

1. Akagi K, Kurahashi H, Arita N, et al: Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer 60:178-182, 1995
2. Bijlsma EK, Merel P, Bosch DA, et al: Analysis of mutations in the SCH gene in schwannomas. Genes Chromosom Cancer 11:7-14, 1994
3. Cavenee WK, Dryja TP, Phillips RA, et al: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784, 1983
4. Doney MK, Houseal TW, Soukup SW, et al: Identification of a putative tumor suppressor locus in 14q24-32 that is involved in formation and progression of meningiomas. Am J Hum Genet (Suppl) 53:293. 1993 (Abstract)
5. Dumanski JP, Carlborn E, Collins VP, et al: Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci USA 84:9275-9279, 1987
6. Dumanski JP, Rouleau GA, Nordenskjöld M, et al: Molecular genetic analysis of chromosome 22 in 81 cases of meningioma. Cancer Res 50:5863-5867, 1990
7. Evans DGR, Huson SM, Donnai D, et al: A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet 29:847-852, 1992
8. Irving RM, Moffat DA, Hardy DG, et al: Molecular genetic analysis of the mechanism of tumorigenesis in acoustic neuroma. Arch Otolaryngol Head Neck Surg 119:1222-1228, 1993
9. Irving RM, Moffat DA, Hardy DG, et al: Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 3:347-350, 1994
10. Jacoby LB, MacCollin M, Louis DN, et al: Exon scanning for mutation of the NF2 gene in schwannomas. Hum Mol Genet 3:413-419, 1994
11. Kanno H, Kondo K, Ito S, et al: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847, 1994
12. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumors of the Central Nervous System, ed 2. Berlin: Springer-Verlag, 1993
13. Knudson AG Jr: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823, 1971
14. Lekanne Deprez RH, Bianchi AB, Groen NA, et al: Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022-1029, 1994
15. Lindblom A, Ruttledge M, Collins VP, et al: Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer 56:354-357, 1994
16. Martuza RL, Eldridge R: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 318:684-688, 1988
17. Peyrard M, Fransson I, Xie YG, et al: Characterization of a new member of the human beta-adaptin gene family from chromosome 22q12, a candidate meningioma gene. Hum Mol Genet 3:1393-1399, 1994
18. Rempel SA, Schwechheimer K, Davis RL, et al: Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 53:2386-2392, 1993
19. Rouleau GA, Merel P, Lutchman M, et al: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521, 1993
20. Russell DS, Rubinstein LJ: Pathology of Tumours of the Nervous System, ed 5. London: Edward Arnold, 1989
21. Ruttledge MH, Sarrazin J, Rangaratnam S, et al: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 6:180-184, 1994
22. Ruttledge MH, Xie YG, Han FY, et al: Deletions on chromosome 22 in sporadic meningioma. Genes Chromosom Cancer 10:122-130, 1994
23. Sainz J, Huynh DP, Figueroa K, et al: Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 3:885-891, 1994
24. Schneider G, Lutz S, Henn W, et al: Search for putative suppressor genes in meningioma: significance of chromosome 22, Hum Genet 88:579-582, 1992
25. Seizinger BR, de la Monte S, Atkins L, et al: Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci USA 84:5419-5423, 1987
26. Seizinger BR, Martuza RL, Gusella JF: Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322:644-647, 1986
27. Trofatter JA, MacCollin MM, Rutter JL, et al: A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800, 1993
28. Twist EC, Ruttledge MH, Rousseau M, et al: The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151, 1994
29. Zwarthoff EC, Riegman PHJ, Groen NA, et al: Cloning of a putative meningioma tumor suppressor gene. Am J Hum Genet (Suppl) 53:164, 1993 (Abstract)